TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: RSS improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sRSA improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Additional dose of midazolam
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Endoscopist satisfaction (visual analog scale score)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: AC distances
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total time asleep
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: respiratory disturbance index of hypopnea
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Use of professional interpretation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in abdominal contour
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in abdominal muscle thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in abdominal fat layer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: GDS score change
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: PGC score change
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: 1RM squat (One Repetition Maximum)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative anatomical success
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity of searching CENTRAL
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number Needed to Review (NNR)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: ICIQ-UI-SF score improvement
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Progression to probable dementia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Risk of becoming positive for a given vaccine‐preventable HPV type
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: walking speed during a 10-m walk test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: walking speed during a 6-min walk test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: distance during a 6-min walk test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of INOCA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Volume of air required to achieve intracuff pressure of 60 cmH2O
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Mean hunger scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Failure proximity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of opioid overdose deaths
Endpoint domain: Mortality/survival
Primary endpoint: Mean left ventricular ejection fraction (LVEF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Overall Response Rate (ORR4)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lymphatic morbidity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative neurological symptoms
Endpoint domain: Adverse events/effects
Primary endpoint: Complete healing of wounds at 3 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in ulcer size at 14 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of depressive disorders
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of anxiety
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: muscle synthesis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: muscle breakdown
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to complete cessation of bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Successful continuation of pregnancy up to 24 weeks
Endpoint domain: Mortality/survival
Primary endpoint: Intraobserver kappa
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Interrater consistency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: First Pass Success - Airway Evaluation (FPS-AE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Locoregional disease-free survival
Endpoint domain: Mortality/survival
Primary endpoint: Gray-matter volume in the right medial temporal lobe
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Photopic pupil diameter (PD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mesopic pupil diameter (PD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Constriction ratio (CR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reaction time (R time)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Kinetics time (K time)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Aggression behaviors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of inappropriate prescriptions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: effective pressing times of PCIA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: dosage of PCIA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: early discharge
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: time to event
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PCL5 score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: suicide prevention-related knowledge
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: suicide prevention-related attitudes
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: suicide prevention-related behaviors
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Overall reattachment rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Single-surgery success
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proliferative vitreoretinopathy development
Endpoint domain: Adverse events/effects
Primary endpoint: Menopause-Specific Quality of Life questionnaire VMS scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Hot Flash-Related Daily Interference Scale
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Greene Climacteric Scale-VMS domain scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Average duration between intervention and discharge
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Fall rates
Endpoint domain: Adverse events/effects
Primary endpoint: Fracture rates
Endpoint domain: Adverse events/effects
Primary endpoint: Rash rates
Endpoint domain: Adverse events/effects
Primary endpoint: %Δ Cmax of oxaliplatin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rate of adequate bowel preparation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post-procedural pain score (PPPS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reuse
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Occurrence of OIIRR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Satisfaction and effectiveness at reducing craving
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Aversive responses
Endpoint domain: Adverse events/effects
Primary endpoint: Daily number of portions of fruits and vegetables consumed
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Overall ratings for attractiveness
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: postextraction dimensional changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: bone resorption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Disease control for >6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maintain HDL-C and LDL-C levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: AVF maturity rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of fistula stenosis
Endpoint domain: Adverse events/effects
Primary endpoint: incidence of fistula thrombosis
Endpoint domain: Adverse events/effects
Primary endpoint: Number of visual impairments per child
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Educational support at school
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Reporting of Confidence Intervals (CIs)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Cumulative recovery rate at seven days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Superior sagittal sinus pressures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Trans‐stenotic pressure gradients
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: bench press 1RM
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: relative 1RM
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ballistic push-up peak power
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: analgesic efficacy of TENS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: potential to reduce opiate usage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-reported breakthrough experiences
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number of unsuccessful continuous blood pressure measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FPG change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: maximum oxygen consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Relative TCS improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DMS improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of uterine hyperstimulation
Endpoint domain: Adverse events/effects
Primary endpoint: Risk of fetal heart rate abnormalities
Endpoint domain: Adverse events/effects
Primary endpoint: Limitation in forearm rotation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative changes in Km at the anterior surface (ΔKm-ant)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Levels of IL-6, PCT, and CRP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in CVD risk factors
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Changes in insulin resistance markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: SDM-related knowledge
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: SDM judging ability
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Total cholesterol <4.0 mmol/L
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Coding for microalbuminuria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Quality of clinical trial reports
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: PASI50
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: improvements in psoriasis signs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reduction in affected BSA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cumulative flare rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DFR (Disease Free Remission)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ARFS (Event-free survival)
Endpoint domain: Mortality/survival
Primary endpoint: KOOS disability score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: performance tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: favorable cognitive performance
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Incident risk of total cancer
Endpoint domain: Mortality/survival
Primary endpoint: Mean change in weekly migraine days at week 4
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain measurement scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-efficacy (CBSEI scores)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: nonparetic normal muscle area
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: incidence of moderate-to-severe postoperative complications
Endpoint domain: Adverse events/effects
Primary endpoint: need for repeat revascularisation
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: AEFE indicators
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: ventilatory threshold
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Non-perfused volume ratio (NPVR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Energy efficiency factor (EEF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ablation time (AT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Non-stone recurrence free (NSRF) rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Perceived financial barriers to screening
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Screening appointment costs
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Follow-up/future treatment costs
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Clinical improvement after surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Contact dermatitis
Endpoint domain: Adverse events/effects
Primary endpoint: Salt intake less than 6 g/day
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Treatment-Related Adverse Events (TRAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Reduced dorsolateral prefrontal cortex response to high-calorie foods
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Reduced response to high-calorie foods in striatum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Reduced high-calorie food ratings
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Total OSBD-R distress score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Parental anxiety immediately after the procedure
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Parental satisfaction with pain management
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: LPS-specific IL-6 concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: LPS-specific MPO concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: TIS (Timed Up and Go Test)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FSS (Fatigue Severity Scale)
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: SDS (Sleep Disturbance Scale)
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: PACU residence time
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Preinduction hypertension incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Major adverse cardiac or cerebrovascular event
Endpoint domain: Mortality/survival
Primary endpoint: Prevalence of recurrent nightmare
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: simple reaction time variability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: reaction accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: 7-day PPA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean BI score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean dexterity value decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean number of hands tapping movements increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of patients meeting the threshold of 'wearing off'
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of liver injury
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: bulging frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: hernia development
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical remission rate at week 252
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: visual analogue scale score improvement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Resting Energy Expenditure (REE) agreement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Confidence with breastfeeding
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Fragrance allergy prevalence
Endpoint domain: Adverse events/effects
Primary endpoint: Swallowing function (Kubota water swallowing test)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Respiratory function (FVC, MVV, maximal expiratory time)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Time to first or transient deterioration
Endpoint domain: Mortality/survival
Primary endpoint: Time until definitive deterioration
Endpoint domain: Mortality/survival
Primary endpoint: Managing dementia behaviors
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Understanding disease expectations
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Performing activity of daily living care
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Amount of hemorrhage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: ease of use score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: caloric intake improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: hemoglobin improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Overall OHRQOL scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: postoperative urinary tract infection
Endpoint domain: Adverse events/effects
Primary endpoint: overall hand function
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Water consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: SAD insertion time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: GT insertion time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: OLP levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reduced lifetime prostate cancer-related deaths
Endpoint domain: Mortality/survival
Primary endpoint: Sero-protection on day 14
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Risk of postoperative infection
Endpoint domain: Adverse events/effects
Primary endpoint: Risk of seromas/hematomas
Endpoint domain: Adverse events/effects
Primary endpoint: Heel pain intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Foot disability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TAG (Triacylglycerol) concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: NEFA (Non-Esterified Fatty Acids) concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes